BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32108326)

  • 21. Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial.
    Li B; Xiang J; Zhang Y; Li H; Zhang J; Sun Y; Hu H; Miao L; Ma L; Luo X; Chen S; Ye T; Zhang Y; Zhang Y; Chen H
    JAMA Surg; 2015 Apr; 150(4):292-8. PubMed ID: 25650816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and safety of minimally invasive Ivor Lewis and McKeown oesophagectomy in Chinese patients with stage IA-IIIB oesophageal squamous cell cancer: a multicentre, non-interventional and observational study.
    Zhang T; Hou X; Li Y; Fu X; Liu L; Xu L; Liu Y
    Interact Cardiovasc Thorac Surg; 2020 Jun; 30(6):812-819. PubMed ID: 32285107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective three-field lymphadenectomy for thoracic esophageal squamous carcinoma.
    Fang WT; Chen WH; Chen Y; Jiang Y
    Dis Esophagus; 2007; 20(3):206-11. PubMed ID: 17509116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
    Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
    J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trial.
    Mu J; Gao S; Mao Y; Xue Q; Yuan Z; Li N; Su K; Yang K; Lv F; Qiu B; Liu D; Chen K; Li H; Yan T; Han Y; Du M; Xu R; Wen Z; Wang W; Shi M; Xu Q; Xu S; He J
    BMJ Open; 2015 Nov; 5(11):e008328. PubMed ID: 26576807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
    Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
    Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oesophageal cancer: how radical should surgery be?
    Mariette C; Piessen G
    Eur J Surg Oncol; 2012 Mar; 38(3):210-3. PubMed ID: 22236956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
    Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.
    Altorki N; Kent M; Ferrara C; Port J
    Ann Surg; 2002 Aug; 236(2):177-83. PubMed ID: 12170022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial.
    Briez N; Piessen G; Bonnetain F; Brigand C; Carrere N; Collet D; Doddoli C; Flamein R; Mabrut JY; Meunier B; Msika S; Perniceni T; Peschaud F; Prudhomme M; Triboulet JP; Mariette C
    BMC Cancer; 2011 Jul; 11():310. PubMed ID: 21781337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer.
    Osugi H; Takemura M; Takada N; Hirohashi K; Kinoshita H; Higashino M
    Br J Surg; 2002 Jul; 89(7):909-13. PubMed ID: 12081742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery.
    Ye B; Zhong CX; Yang Y; Fang WT; Mao T; Ji CY; Li ZG
    World J Gastroenterol; 2016 May; 22(19):4750-6. PubMed ID: 27217706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thoracoscopic and laparoscopic oesophagectomy improves the quality of extended lymphadenectomy.
    Cadière GB; Torres R; Dapri G; Capelluto E; Hainaux B; Himpens J
    Surg Endosc; 2006 Aug; 20(8):1308-9. PubMed ID: 16897282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective Lymphadenectomy for Salvage Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma.
    Mayanagi S; Haneda R; Inoue M; Ishii K; Tsubosa Y
    Ann Surg Oncol; 2022 Aug; 29(8):4863-4870. PubMed ID: 35552931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
    Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy.
    Isono K; Ochiai T; Okuyama K; Onoda S
    Jpn J Surg; 1990 Mar; 20(2):151-7. PubMed ID: 2342235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caveolin-1 in multi drug resistance and two-field lymphadenectomy for thoracic esophageal squamous cell carcinoma.
    Fang W; Ruan W; Lin S; Chen Y; Zhu K
    Pak J Pharm Sci; 2017 Sep; 30(5(Special)):1857-1866. PubMed ID: 29084658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.